The Wayback Machine - https://web.archive.org/web/20111021133309/http://en.wikipedia.org/wiki/Brimonidine

Brimonidine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Brimonidine
Systematic (IUPAC) name
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine
Clinical data
Trade names Alphaganp
AHFS/Drugs.com Consumer Drug Information
MedlinePlus a601232
Pregnancy cat. B
Legal status unknown
Routes Ocular, 1 gtt
Pharmacokinetic data
Metabolism liver primarily
Half-life 3 hours
Identifiers
CAS number 59803-98-4
ATC code S01EA05
PubChem CID 2435
IUPHAR ligand 520
DrugBank APRD00034
ChemSpider 2341 YesY
UNII E6GNX3HHTE YesY
KEGG D07540 YesY
ChEBI CHEBI:3175 YesY
ChEMBL CHEMBL844 YesY
Chemical data
Formula C11H10BrN5 
Mol. mass 292.135 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension.

It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form.

Brimonidine is an α2-adrenergic receptor agonist.

Alpha 2 agonists, through the activation of the Gi GPCR, inhibit the activity of adenylate cyclase. This reduces cAMP and hence aqueous humour production by the ciliary body.

Peripheral alpha 2 agonist activity results in vasoconstriction of blood vessels (as opposed to central alpha 2 agonist activity that decreases sympathetic tone, as can be seen by the medication clonidine). This vasoconstriction may explain the acute reduction in aqueous humor flow. The increased uveoscleral outflow from prolonged use may be explained by increased prostaglandin release due to alpha adreneric stimulation. This may lead to relaxed ciliary muscle and increased uveoscleral outflow [1]

Contents

[edit] Clinical uses

Brimonidine is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is also the active ingredient of Combigan along with timolol maleate.

[edit] References

  1. ^ Toris, C.; Camras, C.; Yablonski, M. (1999). "Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients". American journal of ophthalmology 128 (1): 8–14. PMID 10482088.  edit

[edit] External links

[edit] References

  • Mosby's Drug Guide for Nurses (7th edition; Skidmore) 2007.
Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages
Morty Proxy This is a proxified and sanitized view of the page, visit original site.